Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8639 |
High Similarity |
NPD6190 |
Approved |
0.828 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8217 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8165 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8085 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7945 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7922 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7843 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7798 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7785 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7755 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7751 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD37 |
Approved |
0.774 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7718 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7716 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7716 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7679 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7658 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7644 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7613 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7613 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7589 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5401 |
Approved |
0.753 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1653 |
Approved |
0.75 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7469 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7455 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD228 |
Approved |
0.741 |
Intermediate Similarity |
NPD919 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7372 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD943 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7351 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7346 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7342 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7341 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7337 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.729 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7255 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7208 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2534 |
Approved |
0.72 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD9545 |
Approved |
0.717 |
Intermediate Similarity |
NPD3750 |
Approved |
0.717 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6653 |
Approved |
0.716 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD17 |
Approved |
0.7072 |
Intermediate Similarity |
NPD7296 |
Approved |
0.707 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD7972 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7047 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD826 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD825 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7024 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7021 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7021 |
Intermediate Similarity |
NPD2067 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6777 |
Approved |
0.6989 |
Remote Similarity |
NPD6781 |
Approved |
0.6989 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6779 |
Approved |
0.6989 |
Remote Similarity |
NPD6776 |
Approved |
0.6989 |
Remote Similarity |
NPD6782 |
Approved |
0.6989 |
Remote Similarity |
NPD6780 |
Approved |
0.6989 |
Remote Similarity |
NPD6778 |
Approved |
0.6988 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6981
|
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |